029HO02851 VALIANT

Print/PDF
Registration Name S-W-D VALIANT
Registration Number HOUSA000001650414
Primary NAAB Code 029HO02851
Secondary Code(s)
Status Inactive
Controller Name ABS Global (29)
Date of Birth 6/28/1973
aAa -
DMS -
GFI 5.9%
Genetic Codes * TV TL
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire PAWNEE FARM ARLINDA CHIEF
MGS IRVINGTON PRIDE ADMIRAL
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ -1301, 94% R CM$ -1310
NM Percentile 00% FM$ -1280
GTPI 788 GM$ -1316
PRODUCTION TRAITS
36161 Dtrs 8194 herds 100 % US 99% R
Milk -2846 Fat, % -116 , +0.01%
SCS 3.08, 99% R Protein, % -91 , +0.01%
Feed Saved -99 , 69% R Milking Speed 6.93 , 67% R
Health & Fertility
Productive Life -5.4      99% R Mastitis -0.9      94% R
Heifer Livability -0.9       75% R Metritis -0.6      92% R
Livability -1.4      99% R D. Abom -0.5      93% R
DPR -2.1      99% R Ketosis -1.1      90% R
FSC -11.1      99% R R. Placenta 0.3      92% R
HCR -0.3      94% R Milk Fever 0.1      83% R
CCR -3.3      99% R
SCR -        -
DIA -0.1      46% R
RSP 1.3      57% R
Calving Traits
Sire CE 1.5      99% R 3403 Obs
Daughter CE 3.5      99% R 5645 Obs, 3254 Dtrs
Sire SB 3.9      99% R 1107 Obs
Daughter SB 7.2      99% R 3540 Obs, Dtrs
Gestation Length 1.3      97% R 23 Obs, 30 Dtrs
Early First Calving -1.6      99% R 6938 Obs, 28133 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
29028 Dtrs 6427 herds 99% R
PTA Type -3.47 UDC -4.87
HCC -8.41 BWC -0.15
FLC -2.66
Linear Traits
Stature -1.80
Short
Strength -0.46
Weak
Body Depth -0.15
Shallow
Dairy Form -1.69
Closed
Rump Angle -0.51
Flat
Thurl Width -1.08
Flat
Rear Legs-Side View -1.08
Narrow
Rear Legs-Rear View -2.48
H.-in
Foot Angle -2.15
Low
Feet & Legs Score -2.98
Low
F.U. Attachment -0.01
Straight
Rear Udder Height -5.62
Low
Rear Udder Width -4.89
Narrow
Udder Cleft -3.94
Weak
Udder Depth -2.48
H.-in
Front Teat Placement -3.21
Wide
Rear Teat Placement -3.48
Wide
Teat Length 1.03
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO